Total combined global risk assessment applied to pharmaceutical equivalence – A case study of ofloxacin medicines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Total combined global risk assessment applied to pharmaceutical equivalence – A case study of ofloxacin medicines

Published:2023-10 Issue: Volume:241 Page:104935
ISSN:0169-7439
Container-title:Chemometrics and Intelligent Laboratory Systems
language:en
Short-container-title:Chemometrics and Intelligent Laboratory Systems

Author:

Caffaro Arthur M.,Lourenço Felipe R.^ORCID

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

Spectroscopy,Process Chemistry and Technology,Computer Science Applications,Software,Analytical Chemistry

Reference33 articles.

1. Center for Drug Evaluation and Research (CDER). Evaluation of Therapeutic Equivalence - Guidance for Industry,2022

2. United States Pharmacopeial Convention,2021

3. European Directorate for the Quality of Medicines & HealthCare,2020

4. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty;Bertanha;J. Pharm. Biomed. Anal.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total combined risk of false conformity decisions in pharmaceutical equivalence of acetaminophen oral solution;Microchemical Journal;2024-06

2. Risk Assessment for Linear Regression Models in Metrology;Applied Sciences;2024-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP